Haixia Cheng

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, National Cancer Center, Shanxi Academy of Medical Sciences · ORCID：0000-0001-7565-7099

发表论文 45 篇 · 总被引 1400 次 · h-index 13

代表论文

• Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer (2018 · Nature Communications · 被引 171)
• Integrated time course omics analysis distinguishes immediate therapeutic response from acquired resistance (2018 · Genome Medicine · 被引 33)
• MRI-derived radiomics assessing tumor-infiltrating macrophages enable prediction of immune-phenotype, immunotherapy response and survival in glioma (2024 · Biomarker Research · 被引 29)
• Histopathological auxiliary system for brain tumour (HAS-Bt) based on weakly supervised learning using a WHO CNS5-style pipeline (2023 · Journal of Neuro-Oncology · 被引 12)
• Analysis of the differential expression of serum miR-21-5p, miR-135-5p, and miR-155-5p by Bifidobacterium triplex viable capsules during the perioperative stage of colorectal cancer (2024 · International Journal of Colorectal Disease · 被引 7)
• Refractive status and retinal morphology in children with a history of intravitreal ranibizumab for retinopathy of prematurity (2023 · European Journal of Pediatrics · 被引 5)